|
|
| (11) | Number of the document | C 1040094 |
| (68) | Number of the document | 1040094 |
| (21) | Application number for Supplementary Protection Certificate | PA 2018 513 |
| (22) | Date of filing the application | 2018-09-13 |
| (41) | Date of publication of the application | 2018-10-10 |
| Date of publication of SPC | 2018-11-26 | |
| (24) | Date of coming into effect of SPC | 2018-12-18 |
| (71) |
BIOCRYST PHARMACEUTICALS INC.,
2190 Parkway Lake Drive, Birmingham, Alabama 35244,
US
|
| (73) |
Biocryst Pharmaceuticals, Inc.,
4505 Emperor Boulevard, Suite 200, Durham, North Carolina 27703,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/18/1269, 2018-04-13 |
| (94) | 2023-12-17 |
| (95) | Peramiviras ir jo farmaciniu požiūriu priimtinos druskos |
| Payment date | Validity (years) | Amount | |
| 2022-12-07 | 347.00 EUR |
| SPC expired |